Boots apologises for morning-after pill campaign response

0
Boots apologises for morning-after pill campaign response

BRITISH pharmacy chain Boots has apologised for its response to a campaign calling for it to cut the price of one of its morning-after pills and said it was looking for cheaper alternatives.

Boots was criticised by health campaigners and lawmakers after refusing to cut the cost of the emergency contraception pill, saying it could be accused of ‘incentivising inappropriate use’.

The British Pregnancy Advisory Service (BPAS) campaigned for Boots to cut the price of the Levonelle morning-after pill, saying it was more expensive in Britain than other parts of Europe.

BPAS’s campaign was backed by lawmakers from Britain’s opposition Labour Party.

Boots said pricing EHC was determined by the cost of the medicine and the cost of pharmacy consultation.

‘We are committed to looking at the sourcing of less expensive EHC medicines, for example generics, to enable us to continue to make a privately funded EHC service even more accessible in the future,’ it said.

LEAVE A COMMENT

Please enter your comment!
Please enter your name here

We welcome comments from readers on our website and across our social networks. We invite you to discuss issues and share your views and we encourage robust debate and criticism provided it is civil.

However we reserve the right to reject or edit comments that:

• Contain offensive language
• Include personal attacks of any kind
• Are likely to offend or target any ethnic, racial, nationality or religious group
• Are homophobic, transphobic, sexist, offensive or obscene
• Contain spam or include links to other sites
• Are clearly off topic
• Impersonate an individual or organisation, are fraudulent, defamatory of any person, threatening or invasive of another’s privacy or otherwise illegal
• Are trolling or threatening
• Promote, advertise or solicit the sale of any goods or services

You grant us a non-exclusive, royalty-free, perpetual, worldwide licence to republish any material you submit to us, without limitation, in any format.